https://thelifesciencefeed.com/articles/ra-treatment-optimisation-applying-two-decades-of-progress The Life Science Feed en 2026-06-03 RA Treatment Optimisation: Applying Two Decades of Progress https://thelifesciencefeed.com/articles/eular-2026-polymyalgia-rheumatica-guidelines-rwe The Life Science Feed en 2026-06-03 EULAR 2026: Polymyalgia Rheumatica Guidelines Incorporate RWE https://thelifesciencefeed.com/articles/rapid-sle-control-prevents-organ-damage-eular-2026-focus The Life Science Feed en 2026-06-03 Rapid SLE Control Prevents Organ Damage: EULAR 2026 Focus https://thelifesciencefeed.com/articles/spa-remission-clinical-symptoms-vs-subclinical-inflammation-eular-2026 The Life Science Feed en 2026-06-03 SpA Remission: Clinical Symptoms vs. Subclinical Inflammation at EULAR 2026 https://thelifesciencefeed.com/articles/obesity-management-improves-psoriatic-disease-outcomes The Life Science Feed en 2026-06-03 Obesity Management Improves Psoriatic Disease Outcomes https://thelifesciencefeed.com/articles/sle-pathophysiology-advances-eular-2026-precision-care The Life Science Feed en 2026-06-03 SLE Pathophysiology Advances Inform Future Precision Care at EULAR 2026 https://thelifesciencefeed.com/articles/optimising-psa-axspa-treatment-eular-2026-early-intervention The Life Science Feed en 2026-06-03 Optimising PsA and axSpA Treatment: EULAR 2026 Focuses on Early Intervention https://thelifesciencefeed.com/articles/anca-vasculitis-evolving-strategies-remission-relapse-prevention The Life Science Feed en 2026-06-03 ANCA Vasculitis: Evolving Strategies Target Remission & Relapse Prevention https://thelifesciencefeed.com/articles/car-t-cell-therapy-autoimmune-eular-2026 The Life Science Feed en 2026-06-03 CAR T Cell Therapy Shows Efficacy in Autoimmune Diseases at EULAR 2026 https://thelifesciencefeed.com/articles/lupus-management-progress-persistent-challenges-eular-2026 The Life Science Feed en 2026-06-03 Lupus Management: Progress and Persistent Challenges at EULAR 2026 https://thelifesciencefeed.com/articles/autoantibodies-hidden-drivers-autoimmune-rheumatic-diseases The Life Science Feed en 2026-06-03 Autoantibodies: Hidden Drivers of Autoimmune Rheumatic Diseases https://thelifesciencefeed.com/articles/vexas-syndrome-expert-consensus-multidisciplinary-care-eular-2026 The Life Science Feed en 2026-06-03 VEXAS Syndrome: Expert Consensus on Multidisciplinary Care at EULAR 2026 https://thelifesciencefeed.com/articles/sjogrens-disease-targeting-underlying-activity-beyond-symptoms The Life Science Feed en 2026-06-03 Sjögren’s Disease: Targeting Underlying Activity Beyond Symptoms https://thelifesciencefeed.com/articles/eular-2026-methotrexate-remains-cornerstone-ra-first-line The Life Science Feed en 2026-06-03 EULAR 2026: Methotrexate Remains Cornerstone in RA First-Line https://thelifesciencefeed.com/articles/car-t-cell-therapy-sle-ssc-immune-reset The Life Science Feed en 2026-06-03 CAR T Cell Therapy Shows Promise in SLE and SSc Immune Reset https://thelifesciencefeed.com/articles/multidisciplinary-approach-improves-autoimmune-ild-management The Life Science Feed en 2026-06-03 Multidisciplinary Approach Improves Autoimmune ILD Management https://thelifesciencefeed.com/articles/ra-care-navigating-treatment-choices-eular-2026 The Life Science Feed en 2026-06-02 RA Care: Navigating Treatment Choices at EULAR 2026 https://thelifesciencefeed.com/articles/multidisciplinary-care-improves-spondyloarthritis-outcomes The Life Science Feed en 2026-06-02 Multidisciplinary Care Improves Spondyloarthritis Outcomes https://thelifesciencefeed.com/articles/immuno-fibrotic-crosstalk-rheumatology-eular-2026 The Life Science Feed en 2026-06-02 Immuno-Fibrotic Crosstalk: A New Target in Rheumatology https://thelifesciencefeed.com/articles/treat-to-target-sle-burden-benefit-risk-eular-2026 The Life Science Feed en 2026-06-02 Treat-to-Target in SLE: Balancing Burden, Benefit, and Risk https://thelifesciencefeed.com/articles/early-sle-disease-control-targeting-ifn-pathway-eular-2026 The Life Science Feed en 2026-06-02 Early SLE Disease Control: Targeting IFN Pathway at EULAR 2026 https://thelifesciencefeed.com/articles/eular-2026-psoriatic-disease-spectrum-highlights The Life Science Feed en 2026-06-02 EULAR 2026: Psoriatic Disease Spectrum Highlights https://thelifesciencefeed.com/articles/early-ild-recognition-sard-ssc-drivers-progression-workflow-solutions The Life Science Feed en 2026-06-02 Early ILD Recognition in SARD/SSc: Drivers of Progression and Workflow Solutions https://thelifesciencefeed.com/articles/eular-2026-earlier-axspa-recognition-improves-disease-burden The Life Science Feed en 2026-06-02 EULAR 2026: Earlier AxSpA Recognition Improves Disease Burden https://thelifesciencefeed.com/articles/early-intervention-inflammatory-joint-disease-osteoporosis The Life Science Feed en 2026-06-02 Early Intervention Crucial for Inflammatory Joint Disease, Osteoporosis